Sun Pharma Q4 Results: Pharmaceutical major Sun Pharmaceutical Industries on Thursday, May 22, reported a 19 per cent year-on-year (YoY) fall in Q4FY25 consolidated profit to ₹2,153.93 crore against a profit of ₹2,658.74 crore in the corresponding quarter of the previous financial year.
Total revenue from operations, however, increased 8 per cent YoY to ₹12,958.84 crore from ₹11,982.90 crore in the corresponding quarter of the previous financial year.
(This is a developing story. Please check back for fresh updates.)